Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications

Awgichew Shewasinad Yehualashet Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, De...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Yehualashet AS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
tlr
Acceso en línea:https://doaj.org/article/9f3839308f7d4602a01fe8691e2cf57b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f3839308f7d4602a01fe8691e2cf57b
record_format dspace
spelling oai:doaj.org-article:9f3839308f7d4602a01fe8691e2cf57b2021-12-02T11:42:27ZToll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications1178-7007https://doaj.org/article/9f3839308f7d4602a01fe8691e2cf57b2020-12-01T00:00:00Zhttps://www.dovepress.com/toll-like-receptors-as-a-potential-drug-target-for-diabetes-mellitus-a-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Awgichew Shewasinad Yehualashet Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaTel +251935450290Email awgshewa@gmail.comAbstract: Diabetes mellitus (DM) is a chronic endocrine disease distinguished by hyperglycemia due to disturbance in carbohydrate or lipid metabolism or insulin function. To date, diabetes, and its complications, is established as a global cause of morbidity and mortality. The intended aim during the management of diabetes is to maintain blood glucose close to normal because the majority of patients have poor control of their elevated blood glucose and are highly prone to severe macrovascular and microvascular complications. To decrease the burden of the disease and its complications, scientists from various disciplines are working intensively to identify novel and promising drug targets for diabetes and its complications. Increased and ongoing investigations on mechanisms relating to diabetes and associated complications could potentially consider inflammatory cascades as a promising component of the strategy in the prevention and control of diabetes and its complications. The potential of targeting mediators of inflammation like toll-like receptors (TLRs) are part of current investigation by the scientific community. Hence, the aim of the present review is to discuss the role of TLRs as a potential drug target for diabetes and diabetes associated complications.Keywords: diabetes mellitus, TLR, immunity, inflammation, complicationYehualashet ASDove Medical Pressarticlediabetes mellitustlrimmunityinflammationcomplicationSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 4763-4777 (2020)
institution DOAJ
collection DOAJ
language EN
topic diabetes mellitus
tlr
immunity
inflammation
complication
Specialties of internal medicine
RC581-951
spellingShingle diabetes mellitus
tlr
immunity
inflammation
complication
Specialties of internal medicine
RC581-951
Yehualashet AS
Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
description Awgichew Shewasinad Yehualashet Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaTel +251935450290Email awgshewa@gmail.comAbstract: Diabetes mellitus (DM) is a chronic endocrine disease distinguished by hyperglycemia due to disturbance in carbohydrate or lipid metabolism or insulin function. To date, diabetes, and its complications, is established as a global cause of morbidity and mortality. The intended aim during the management of diabetes is to maintain blood glucose close to normal because the majority of patients have poor control of their elevated blood glucose and are highly prone to severe macrovascular and microvascular complications. To decrease the burden of the disease and its complications, scientists from various disciplines are working intensively to identify novel and promising drug targets for diabetes and its complications. Increased and ongoing investigations on mechanisms relating to diabetes and associated complications could potentially consider inflammatory cascades as a promising component of the strategy in the prevention and control of diabetes and its complications. The potential of targeting mediators of inflammation like toll-like receptors (TLRs) are part of current investigation by the scientific community. Hence, the aim of the present review is to discuss the role of TLRs as a potential drug target for diabetes and diabetes associated complications.Keywords: diabetes mellitus, TLR, immunity, inflammation, complication
format article
author Yehualashet AS
author_facet Yehualashet AS
author_sort Yehualashet AS
title Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
title_short Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
title_full Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
title_fullStr Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
title_full_unstemmed Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
title_sort toll-like receptors as a potential drug target for diabetes mellitus and diabetes-associated complications
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/9f3839308f7d4602a01fe8691e2cf57b
work_keys_str_mv AT yehualashetas tolllikereceptorsasapotentialdrugtargetfordiabetesmellitusanddiabetesassociatedcomplications
_version_ 1718395359041945600